Cabozantinib S-malate

SEP 9, 2026 · PHASE 2 TRIAL

Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 2 trial registry record with no results posted; the study is active but not recruiting, and outcome data are not yet reported in this source.

AUG 4, 2026 · PHASE 2 TRIAL

Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

ClinicalTrials.gov

This is an active Phase 2 trial registration with no results posted; the study design and rationale are described but no efficacy or safety outcomes are reported.